Why is Jetting different?

Most agarose-based resins on the market are produced using 'batch emulsification' technology. This was used to manufacture the very first agarose-based chromatography resins, around 60 years ago. Batch emulsification produces a relatively wide particle size distribution which also contains fine particles. These can increase back pressure and block column nets - not ideal for the increasing demands of modern downstream processing. 

Jetting, on the other hand, is a patented manufacturing process, which creates chromatographic resin beads with a uniform particle size distribution and no fine particles. This results in a multitude of benefits, from shorter lead times, to improved bead characteristics, to the possibility to create custom-designed bioprocessing resins specifically for our customers. 

Jetting is being utilized by leading biopharmaceutical developers all over the world to streamline their mAb processes. Get in touch with our R&D and Applications scientists today, to see how Jetting technology can help you.

Performance

  • Reduced time in facility
  • Higher productivity
  • No net clogging or expensive packing failures
  • Precise lot-to-lot reproducibility
  • Custom particle sizes (available on request)


SECURITY OF SUPPLY

  • Dual-continent manufacture (UK and USA) in 2021
  • Industry-leading capacity
  • ISO-accredited facilities

Dr. Patrick Gilbert (R&D Manager) on Jetting technology

Agarose Chromatography Resins Products by Application